{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:07:12Z","timestamp":1794013632697,"version":"4.8.0"},"reference-count":97,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1001\/jamaneurol.2019.1534","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T11:31:01Z","timestamp":1560771061000},"page":"1035","source":"Crossref","is-referenced-by-count":741,"title":["Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology"],"prefix":"10.1001","volume":"76","author":[{"given":"Claire","family":"Bridel","sequence":"first","affiliation":[{"name":"Neurochemistry Laboratory, Department of Clinical Chemistry, VU University Medical Centre, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wessel N.","family":"van Wieringen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, the Netherlands"},{"name":"Department of Mathematics, VU University, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"},{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, United Kingdom"},{"name":"Dementia Research Institute at UCL, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty M.","family":"Tijms","sequence":"additional","affiliation":[{"name":"Department of Neurology and Alzheimer Centre, VU University Medical Centre, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte E.","family":"Teunissen","sequence":"additional","affiliation":[{"name":"Neurochemistry Laboratory, Department of Clinical Chemistry, VU University Medical Centre, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"and the NFL Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C.","family":"Alvarez-Cerme\u00f1o","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Unit, Ramon y Cajal University Hospital, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Andreasson","sequence":"additional","affiliation":[{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Axelsson","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"B\u00e4ckstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Neuroscience, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Bartos","sequence":"additional","affiliation":[{"name":"Third Faculty of Medicine, Department of Neurology, Charles University and General University Hospital, Prague, Czech Republic"},{"name":"National Institute of Mental Health, Klecany, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bjerke","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Reference Centre for Biological Markers of Dementia (BIODEM), Institute Born Bunge, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"},{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Boxer","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lou","family":"Brundin","sequence":"additional","affiliation":[{"name":"Neuroimmunology Unit, Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Neurology, Karolinska University Hospital Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Burman","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenk\u00e1","family":"Fialov\u00e1","sequence":"additional","affiliation":[{"name":"First Faculty of Medicine, Institute of Medical Biochemistry, Prague, Czech Republic"},{"name":"Laboratory Diagnostics, Charles University and General University Hospital, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Forsgren","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Neuroscience, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette L.","family":"Frederiksen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Gissl\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Gray","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gunnarsson","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Health, Orebro University Hospital, Orebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hall","sequence":"additional","affiliation":[{"name":"Clinical Memory Research Unit, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden"},{"name":"Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[{"name":"Clinical Memory Research Unit, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden"},{"name":"Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan K.","family":"Herbert","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg"},{"name":"Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Jakobsson","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Jessen-Krut","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shorena","family":"Janelidze","sequence":"additional","affiliation":[{"name":"Clinical Memory Research Unit, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden"},{"name":"Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg"},{"name":"Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jonsson","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Kappos","sequence":"additional","affiliation":[{"name":"Department of Medicine, University Hospital and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Khademi","sequence":"additional","affiliation":[{"name":"Neuroimmunology Unit, Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Neurology, Karolinska University Hospital Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Khalil","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kuhle","sequence":"additional","affiliation":[{"name":"Department of Medicine, University Hospital and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Land\u00e9n","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"Leinonen","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Neurosurgery, University of Eastern Finland, Kuopio"},{"name":"Department of Neurosurgery, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Logroscino","sequence":"additional","affiliation":[{"name":"Unit of Neurodegenerative Diseases, Department of Clinical Research in Neurology, University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hua","family":"Lu","sequence":"additional","affiliation":[{"name":"North-East London and Essex MND Care Centre, Neuroscience and Trauma Centre, Blizard, United Kingdom"},{"name":"Department of Neurology, China Medical University Hospital, Taichung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lycke","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia K.","family":"Magdalinou","sequence":"additional","affiliation":[{"name":"Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, Queen Square, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Malaspina","sequence":"additional","affiliation":[{"name":"North-East London and Essex MND Care Centre, Neuroscience and Trauma Centre, Blizard, United Kingdom"},{"name":"Institute of Cell and Molecular Medicine, Barts, United Kingdom"},{"name":"London School of Medicine and Dentistry, Barts, United Kingdom"},{"name":"Barts Health NHS Trust, Barts, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Mattsson","sequence":"additional","affiliation":[{"name":"Clinical Memory Research Unit, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden"},{"name":"Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieke H.","family":"Meeter","sequence":"additional","affiliation":[{"name":"Alzheimer Centre and Department of Neurology, Erasmus Medical Centre, Rotterdam, the Netherlands"},{"name":"Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay R.","family":"Mehta","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Modvig","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Copenhagen University Hospital, Righospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Olsson","sequence":"additional","affiliation":[{"name":"Neuroimmunology Unit, Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Neurology, Karolinska University Hospital Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross W.","family":"Paterson","sequence":"additional","affiliation":[{"name":"Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josu\u00e9","family":"P\u00e9rez-Santiago","sequence":"additional","affiliation":[{"name":"Puerto Rico OMICS Centre, University of Puerto Rico Comprehensive Cancer Centre, San Juan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Piehl","sequence":"additional","affiliation":[{"name":"Neuroimmunology Unit, Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Neurology, Karolinska University Hospital Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande A. L.","family":"Pijnenburg","sequence":"additional","affiliation":[{"name":"Department of Neurology and Alzheimer Centre, VU University Medical Centre, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okko T.","family":"Pyykk\u00f6","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Neurosurgery, University of Eastern Finland, Kuopio"},{"name":"Department of Neurosurgery, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Ragnarsson","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Health, Orebro University Hospital, Orebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C.","family":"Rojas","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe","family":"Romme Christensen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Sandberg","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Neuroscience, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole S.","family":"Scherling","sequence":"additional","affiliation":[{"name":"Department of Psychological Science and Neuroscience Program, Belmont University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Schott","sequence":"additional","affiliation":[{"name":"Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn T.","family":"Sellebjerg","sequence":"additional","affiliation":[{"name":"Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella L.","family":"Simone","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy"},{"name":"San Camillo Forlanini Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Skillb\u00e4ck","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Stilund","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Neuroscience, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Svenningsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Tortelli","sequence":"additional","affiliation":[{"name":"Unit of Neurodegenerative Diseases, Department of Clinical Research in Neurology, University of Bari, Bari, Italy"},{"name":"Pia Fondazione Cardinale G. Panico, Tricase, Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Tortorella","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Trentini","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Specialist Surgical Sciences, University of Ferrara, Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Troiano","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Turner","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"van Swieten","sequence":"additional","affiliation":[{"name":"Alzheimer Centre and Department of Neurology, Erasmus Medical Centre, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"V\u00e5gberg","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Neuroscience, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel M.","family":"Verbeek","sequence":"additional","affiliation":[{"name":"Radboud University Medical Centre, Donders Institute for Brain, Cognition, and Behaviour, Department of Neurology, Nijmegen, the Netherlands"},{"name":"Department of Laboratory Medicine, Radboud Alzheimer Centre, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa M.","family":"Villar","sequence":"additional","affiliation":[{"name":"Immunology Department, Ramon y Cajal University Hospital, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter Jelle","family":"Visser","sequence":"additional","affiliation":[{"name":"Department of Neurology and Alzheimer Centre, VU University Medical Centre, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands"},{"name":"Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht University, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Wallin","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Weiss","sequence":"additional","affiliation":[{"name":"Evotec AG, Manfred Eigen Campus, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Wikkels\u00f8","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Wild","sequence":"additional","affiliation":[{"name":"UCL Institute of Neurology, Queen Square, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"noi190040r1","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.","volume":"67","author":"Rosengren","year":"1996","journal-title":"J Neurochem"},{"issue":"5","key":"noi190040r2","doi-asserted-by":"publisher","first-page":"e63172","DOI":"10.1371\/journal.pone.0063172","article-title":"Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.","volume":"8","author":"Khademi","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"noi190040r3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement.","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"issue":"6","key":"noi190040r4","first-page":"805","volume":"18","author":"Vandenbroucke","year":"2007"},{"issue":"8","key":"noi190040r5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"issue":"1-2","key":"noi190040r6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jim.2009.09.014","article-title":"Neurofilament ELISA validation.","volume":"352","author":"Petzold","year":"2010","journal-title":"J Immunol Methods"},{"issue":"5","key":"noi190040r7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1177\/1352458512443092","article-title":"Neurofilaments as biomarkers in multiple sclerosis.","volume":"18","author":"Teunissen","year":"2012","journal-title":"Mult Scler"},{"issue":"8","key":"noi190040r8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/14737159.2017.1341313","article-title":"Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.","volume":"17","author":"Yilmaz","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"noi190040r9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"issue":"6","key":"noi190040r10","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d.","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"issue":"2","key":"noi190040r11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria.","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"issue":"3","key":"noi190040r12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging\u2013Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"6","key":"noi190040r13","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria [published correction appears in Lancet Neurol. 2014;13(8):757].","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"issue":"3","key":"noi190040r14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases.","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"noi190040r15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease.","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch Neurol"},{"issue":"12","key":"noi190040r16","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/(ISSN)1531-8257","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease.","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"issue":"4","key":"noi190040r17","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1212\/WNL.46.4.922","article-title":"Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).","volume":"46","author":"Litvan","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"noi190040r18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","article-title":"Consensus statement on the diagnosis of multiple system atrophy.","volume":"163","author":"Gilman","year":"1999","journal-title":"J Neurol Sci"},{"issue":"2","key":"noi190040r19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ana.v70.2","article-title":"Clinicopathological correlations in corticobasal degeneration.","volume":"70","author":"Lee","year":"2011","journal-title":"Ann Neurol"},{"issue":"4","key":"noi190040r20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/jnnp-2011-300875","article-title":"Diagnostic criteria for corticobasal syndrome: a comparative study.","volume":"83","author":"Mathew","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"noi190040r21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"noi190040r22","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"issue":"4","key":"noi190040r23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/jnnp.57.4.416","article-title":"Clinical and neuropathological criteria for frontotemporal dementia.","volume":"57","author":"The Lund and Manchester Groups","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5-6","key":"noi190040r24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/21678421.2015.1049183","article-title":"A revision of the El Escorial criteria: 2015.","volume":"16","author":"Ludolph","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"8","key":"noi190040r25","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1136\/jnnp.51.8.1037","article-title":"Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study.","volume":"51","author":"Erkinjuntti","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"noi190040r26","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/neurosurgery\/57.3.N4","article-title":"Diagnosing idiopathic normal-pressure hydrocephalus.","volume":"57","author":"Relkin","year":"2005","journal-title":"Neurosurgery"},{"issue":"1","key":"noi190040r27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1017\/S1355617703910071","article-title":"Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments.","volume":"9","author":"Gonzalez","year":"2003","journal-title":"J Int Neuropsychol Soc"},{"issue":"6","key":"noi190040r28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00702-013-1156-0","article-title":"Non-neurological surgery and cerebrospinal fluid biomarkers for neuronal and astroglial integrity.","volume":"121","author":"Anckars\u00e4ter","year":"2014","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"noi190040r29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1352458513490544","article-title":"Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.","volume":"20","author":"Axelsson","year":"2014","journal-title":"Mult Scler"},{"issue":"10","key":"noi190040r30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jamaneurol.2015.1449","article-title":"Cerebrospinal fluid patterns and the risk of future dementia in early, incident Parkinson disease.","volume":"72","author":"B\u00e4ckstr\u00f6m","year":"2015","journal-title":"JAMA Neurol"},{"issue":"3","key":"noi190040r31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3233\/JAD-2011-110566","article-title":"Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer\u2019s disease.","volume":"27","author":"Bjerke","year":"2011","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"noi190040r32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1159\/000366119","article-title":"Cerebrovascular biomarker profile is related to white matter disease and ventricular dilation in a LADIS substudy.","volume":"4","author":"Bjerke","year":"2014","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"1","key":"noi190040r33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000341576","article-title":"Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: the LADIS study.","volume":"34","author":"Jonsson","year":"2012","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"5","key":"noi190040r34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.exger.2011.09.008","article-title":"Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants.","volume":"47","author":"Bruno","year":"2012","journal-title":"Exp Gerontol"},{"issue":"2","key":"noi190040r35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/ane.2014.130.issue-2","article-title":"Assessing tissue damage in multiple sclerosis: a biomarker approach.","volume":"130","author":"Burman","year":"2014","journal-title":"Acta Neurol Scand"},{"issue":"1-2","key":"noi190040r36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jneuroim.2013.03.009","article-title":"Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis.","volume":"259","author":"Fialov\u00e1","year":"2013","journal-title":"J Neuroimmunol"},{"issue":"3","key":"noi190040r37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.5507\/bp.2017.038","article-title":"Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation.","volume":"161","author":"Fialov\u00e1","year":"2017","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"1","key":"noi190040r38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ana.v69.1","article-title":"Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.","volume":"69","author":"Gunnarsson","year":"2011","journal-title":"Ann Neurol"},{"issue":"11","key":"noi190040r39","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders.","volume":"69","author":"Hall","year":"2012","journal-title":"Arch Neurol"},{"issue":"1","key":"noi190040r40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1212\/WNL.0000000000001098","article-title":"CSF biomarkers and clinical progression of Parkinson disease.","volume":"84","author":"Hall","year":"2015","journal-title":"Neurology"},{"issue":"May","key":"noi190040r41","first-page":"91","article-title":"CSF neurofilament light chain but not FLT3 ligand discriminates parkinsonian disorders.","volume":"6","author":"Herbert","year":"2015","journal-title":"Front Neurol"},{"key":"noi190040r42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4137\/JCNSD.S13821","article-title":"Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke.","volume":"6","author":"Hjalmarsson","year":"2014","journal-title":"J Cent Nerv Syst Dis"},{"issue":"10","key":"noi190040r43","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1038\/npp.2014.81","article-title":"Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients.","volume":"39","author":"Jakobsson","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"noi190040r44","doi-asserted-by":"publisher","first-page":"e0127100","DOI":"10.1371\/journal.pone.0127100","article-title":"Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls.","volume":"10","author":"Rolstad","year":"2015","journal-title":"PLoS One"},{"issue":"15","key":"noi190040r45","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1212\/WNL.0b013e31828c2fda","article-title":"Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers.","volume":"80","author":"Jeppsson","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"noi190040r46","doi-asserted-by":"publisher","first-page":"e88591","DOI":"10.1371\/journal.pone.0088591","article-title":"Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.","volume":"9","author":"Jessen Krut","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"noi190040r47","doi-asserted-by":"publisher","first-page":"e0122048","DOI":"10.1371\/journal.pone.0122048","article-title":"Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.","volume":"10","author":"Aeinehband","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"noi190040r48","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/1352458512458010","article-title":"CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.","volume":"19","author":"Khalil","year":"2013","journal-title":"Mult Scler"},{"issue":"12","key":"noi190040r49","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1177\/1352458513482374","article-title":"A comparative study of CSF neurofilament light and heavy chain protein in MS.","volume":"19","author":"Kuhle","year":"2013","journal-title":"Mult Scler"},{"issue":"6","key":"noi190040r50","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1111\/ane.12151","article-title":"Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.","volume":"128","author":"Kuhle","year":"2013","journal-title":"Acta Neurol Scand"},{"issue":"16","key":"noi190040r51","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1212\/WNL.0000000000001491","article-title":"Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis.","volume":"84","author":"Kuhle","year":"2015","journal-title":"Neurology"},{"issue":"11","key":"noi190040r52","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","article-title":"A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.","volume":"86","author":"Magdalinou","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"noi190040r53","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1177\/1352458514549397","article-title":"Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.","volume":"21","author":"Mart\u00ednez","year":"2015","journal-title":"Mult Scler"},{"issue":"8","key":"noi190040r54","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/acn3.325","article-title":"Neurofilament light chain: a biomarker for genetic frontotemporal dementia.","volume":"3","author":"Meeter","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"noi190040r55","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/acn3.212","article-title":"CSF neurofilament light chain reflects corticospinal tract degeneration in ALS.","volume":"2","author":"Menke","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"issue":"22","key":"noi190040r56","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis [published correction appears in Neurology. 2015;85(10):921].","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"issue":"10","key":"noi190040r57","doi-asserted-by":"publisher","first-page":"e77163","DOI":"10.1371\/journal.pone.0077163","article-title":"Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis.","volume":"8","author":"Modvig","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"noi190040r58","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1177\/1352458515599074","article-title":"Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis.","volume":"22","author":"Modvig","year":"2016","journal-title":"Mult Scler"},{"issue":"14","key":"noi190040r59","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1177\/1352458515574148","article-title":"Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis.","volume":"21","author":"Modvig","year":"2015","journal-title":"Mult Scler"},{"issue":"12","key":"noi190040r60","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1007\/s00415-015-7904-3","article-title":"Dissecting IWG-2 typical and atypical Alzheimer\u2019s disease: insights from cerebrospinal fluid analysis.","volume":"262","author":"Paterson","year":"2015","journal-title":"J Neurol"},{"issue":"2","key":"noi190040r61","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s13365-015-0384-5","article-title":"Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection.","volume":"22","author":"P\u00e9rez-Santiago","year":"2016","journal-title":"J Neurovirol"},{"issue":"4","key":"noi190040r62","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.dadm.2015.11.001","article-title":"Discriminative and prognostic potential of cerebrospinal fluid phosphoTau\/tau ratio and neurofilaments for frontotemporal dementia subtypes.","volume":"1","author":"Pijnenburg","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"issue":"3","key":"noi190040r63","doi-asserted-by":"publisher","first-page":"e91974","DOI":"10.1371\/journal.pone.0091974","article-title":"Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.","volume":"9","author":"Pyykk\u00f6","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"noi190040r64","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1530\/EJE-13-0205","article-title":"Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing\u2019s syndrome in remission.","volume":"169","author":"Ragnarsson","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"17","key":"noi190040r65","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1212\/WNL.0000000000000361","article-title":"Natalizumab in progressive MS: results of an open-label, phase 2A, proof-of-concept trial.","volume":"82","author":"Romme Christensen","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"noi190040r66","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.resuscitation.2013.10.032","article-title":"Cerebrospinal fluid biomarkers in cardiac arrest survivors.","volume":"85","author":"Ros\u00e9n","year":"2014","journal-title":"Resuscitation"},{"issue":"8","key":"noi190040r67","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/1352458515606986","article-title":"Vitamin D and axonal injury in multiple sclerosis.","volume":"22","author":"Sandberg","year":"2016","journal-title":"Mult Scler"},{"issue":"1","key":"noi190040r68","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ana.24052","article-title":"Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.","volume":"75","author":"Scherling","year":"2014","journal-title":"Ann Neurol"},{"issue":"21","key":"noi190040r69","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1212\/WNL.0000000000001015","article-title":"CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival.","volume":"83","author":"Skillb\u00e4ck","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"noi190040r70","doi-asserted-by":"publisher","first-page":"e0119681","DOI":"10.1371\/journal.pone.0119681","article-title":"Biomarkers of inflammation and axonal degeneration\/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF\/serum ratio to a biomarker panel.","volume":"10","author":"Stilund","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"noi190040r71","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/ene.2014.22.issue-1","article-title":"Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis.","volume":"22","author":"Tortelli","year":"2015","journal-title":"Eur J Neurol"},{"issue":"12","key":"noi190040r72","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/j.1468-1331.2012.03777.x","article-title":"Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.","volume":"19","author":"Tortelli","year":"2012","journal-title":"Eur J Neurol"},{"issue":"4","key":"noi190040r73","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/1352458514546789","article-title":"Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis.","volume":"21","author":"Tortorella","year":"2015","journal-title":"Mult Scler"},{"issue":"12","key":"noi190040r74","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1007\/s00415-014-7507-4","article-title":"N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis.","volume":"261","author":"Trentini","year":"2014","journal-title":"J Neurol"},{"issue":"8","key":"noi190040r75","doi-asserted-by":"publisher","first-page":"e0135886","DOI":"10.1371\/journal.pone.0135886","article-title":"Levels and age dependency of neurofilament light and glial fibrillary acidic protein in healthy individuals and their relation to the brain parenchymal fraction.","volume":"10","author":"V\u00e5gberg","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"noi190040r76","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/ene.2015.22.issue-8","article-title":"Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.","volume":"22","author":"Villar","year":"2015","journal-title":"Eur J Neurol"},{"issue":"5","key":"noi190040r77","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1172\/JCI80743","article-title":"Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients.","volume":"125","author":"Wild","year":"2015","journal-title":"J Clin Invest"},{"issue":"1","key":"noi190040r78","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression.","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol"},{"issue":"2","key":"noi190040r79","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/(ISSN)1096-9861","article-title":"Neocortical neuron number in humans: effect of sex and age.","volume":"384","author":"Pakkenberg","year":"1997","journal-title":"J Comp Neurol"},{"issue":"5","key":"noi190040r80","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S1474-4422(12)70059-5","article-title":"Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects.","volume":"11","author":"Cohen","year":"2012","journal-title":"Lancet Neurol"},{"issue":"2","key":"noi190040r81","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbadis.2010.07.007","article-title":"Inflammation, demyelination, and degeneration - recent insights from MS pathology.","volume":"1812","author":"Stadelmann","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"noi190040r82","doi-asserted-by":"publisher","first-page":"e75091","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS One"},{"key":"noi190040r83","article-title":"Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis [published correction appears in Mult Scler. 2019;25(2):302].","author":"Tortorella","journal-title":"Mult Scler J"},{"issue":"7","key":"noi190040r84","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1212\/01.WNL.0000055926.69643.03","article-title":"Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.","volume":"60","author":"De Stefano","year":"2003","journal-title":"Neurology"},{"issue":"12","key":"noi190040r85","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1212\/01.WNL.0000098880.19793.B6","article-title":"Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS.","volume":"61","author":"Malmestr\u00f6m","year":"2003","journal-title":"Neurology"},{"issue":"9","key":"noi190040r86","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1212\/01.WNL.0000142988.49341.D1","article-title":"Neurofilament and glial fibrillary acidic protein in multiple sclerosis.","volume":"63","author":"Norgren","year":"2004","journal-title":"Neurology"},{"issue":"14","key":"noi190040r87","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1212\/WNL.0b013e3182143345","article-title":"After the storm: neurofilament levels as a surrogate endpoint for neuroaxonal damage.","volume":"76","author":"Giovannoni","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"noi190040r88","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1212\/WNL.0000000000004088","article-title":"CSF sAPP\u00df, YKL-40, and neurofilament light in frontotemporal lobar degeneration.","volume":"89","author":"Alcolea","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"noi190040r89","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00415-009-0131-z","article-title":"CSF neurofilament protein analysis in the differential diagnosis of ALS.","volume":"256","author":"Reijn","year":"2009","journal-title":"J Neurol"},{"issue":"3","key":"noi190040r90","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10072-016-2783-7","article-title":"Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson\u2019s disease: a meta-analysis.","volume":"38","author":"Hu","year":"2017","journal-title":"Neurol Sci"},{"issue":"1","key":"noi190040r91","doi-asserted-by":"publisher","first-page":"14114","DOI":"10.1038\/s41598-017-14179-1","article-title":"Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington\u2019s disease R6\/2 mice.","volume":"7","author":"Soylu-Kucharz","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"noi190040r92","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1212\/NXI.0000000000000271","article-title":"Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.","volume":"3","author":"Bergman","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"noi190040r93","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.dadm.2015.12.004","article-title":"Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics.","volume":"2","author":"Teunissen","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"issue":"pt 4","key":"noi190040r94","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/brain\/awf080","article-title":"The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.","volume":"125","author":"Hughes","year":"2002","journal-title":"Brain"},{"issue":"1","key":"noi190040r95","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jalz.2005.11.001","article-title":"Comparison of clinical and neuropathologic diagnoses of Alzheimer\u2019s disease in 3 epidemiologic samples.","volume":"2","author":"Plassman","year":"2006","journal-title":"Alzheimers Dement"},{"issue":"6","key":"noi190040r96","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jalz.2011.10.008","article-title":"Comparison of International Working Group criteria and National Institute on Aging\u2013Alzheimer\u2019s Association criteria for Alzheimer\u2019s disease.","volume":"8","author":"Visser","year":"2012","journal-title":"Alzheimers Dement"},{"issue":"12","key":"noi190040r97","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1161\/01.STR.31.12.2952","article-title":"Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia.","volume":"31","author":"Pohjasvaara","year":"2000","journal-title":"Stroke"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/article-pdf\/76\/9\/1035\/17885786\/jamaneurology_bridel_2019_oi_190040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T04:57:36Z","timestamp":1609909056000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2735955"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2019,9,1]]},"references-count":97,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2019.1534","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736003001.793568278","asserted-by":"object"}]},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,1]]}}}